APPLIED DNA SCIENCES INC Contracts & Agreements

Share Purchase Agreement, dated July 12, 2023, by and among Spindle Acquisition Corp., Spindle Biotech Inc., the persons listed on Schedule 1.1 therein, Lai Him Chung and Applied... (Filed With SEC on July 13, 2023)

Form of Restricted Stock Unit Award Agreement (Filed With SEC on March 28, 2023)

Amended and Restated Lease Agreement, dated February 24, 2023, by and between Long Island High Technology Incubator, Inc. and Applied DNA Sciences, Inc. (Office Lease) (Filed With SEC on February 28, 2023)

Amended and Restated Lease Agreement, dated February 24, 2023, by and between Long Island High Technology Incubator, Inc. and Applied DNA Sciences, Inc. (Laboratory Lease) (Filed With SEC on February 28, 2023)

Office Lease Renewal Letter Agreement, dated February 1, 2022, by and between Long Island High Technology Incubator, Inc. and Applied DNA Sciences, Inc (Filed With SEC on December 14, 2022)

Laboratory Lease Renewal Letter Agreement, dated February 1, 2022, by and between Long Island High Technology Incubator, Inc. and Applied DNA Sciences, Inc (Filed With SEC on December 14, 2022)

Contract Number T212206, dated August 3, 2021, by and between The City University of New York and Applied DNA Clinical Labs, LLC (Filed With SEC on December 14, 2022)

First Amendment to Contract No. T212206, dated December 16, 2021, by and between The City University of New York and Applied DNA Clinical Labs, LLC (Filed With SEC on December 14, 2022)

Second Amendment to Contract No. T212206, dated July 19, 2022, by and between The City University of New York and Applied DNA Clinical Labs, LLC (Filed With SEC on December 14, 2022)

Form of Series A Warrant (Filed With SEC on August 9, 2022)

Form of Series B Warrant (Filed With SEC on August 9, 2022)

Form of Prefunded Warrant (Filed With SEC on August 9, 2022)

Form of Securities Purchase Agreement, dated August 4, 2022, by and between Applied DNA Sciences, Inc. and certain purchasers (Filed With SEC on August 9, 2022)

Form of Series A Warrant (Filed With SEC on August 1, 2022)

Form of Series B Warrant (Filed With SEC on August 1, 2022)

Form of Pre-Funded Warrant (Filed With SEC on August 1, 2022)

Form of Securities Purchase Agreement (Filed With SEC on August 1, 2022)

Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on February 23, 2022)

Form of Common Stock Purchase Warrant (Filed With SEC on February 23, 2022)

Form of Placement Agency Agreement by and between Applied DNA Sciences, Inc. and Roth Capital Partners, LLC, dated February 21, 2022 (Filed With SEC on February 23, 2022)

Form of Securities Purchase Agreement (Filed With SEC on February 23, 2022)

Letter Agreement dated March 2, 2021, by and between the Company and Dr. James Hayward (Filed With SEC on March 4, 2021)

Form of Placement Agency Agreement by and between Applied DNA Sciences, Inc. and Roth Capital Partners, LLC, dated January 10, 2021 (Filed With SEC on January 11, 2021)

Form of Securities Purchase Agreement (Filed With SEC on January 11, 2021)

Description of Securities (Filed With SEC on December 17, 2020)

Joint Development Agreement, dated September 11, 2018, between LineaRx, Inc., Takis S.R.L. and Evvivax S.R.L., as amended by that First Amendment, dated February 3, 2020 (Filed With SEC on December 17, 2020)

Animal Clinical Trial Agreement, dated September 14, 2020, between Applied DNA Sciences, Inc., Evvivax S.R.L. and Veterinary Oncology Services, PLLC (Filed With SEC on December 17, 2020)

Warrant Exercise Agreement, dated October 7, 2020, by and between Applied DNA Sciences, Inc. and Dillon Hill Capital, LLC (Filed With SEC on October 14, 2020)

Warrant Exercise Agreement, dated October 7, 2020, by and between Applied DNA Sciences, Inc. and Dillon Hill Investment Company LLC (Filed With SEC on October 14, 2020)

Form of Common Stock Purchase Warrant (Filed With SEC on October 14, 2020)

Registration Rights Agreement, dated October 7, 2020, by and between Applied DNA Sciences, Inc. and Dillon Hill Capital, LLC (Filed With SEC on October 14, 2020)

Registration Rights Agreement, dated October 7, 2020, by and between Applied DNA Sciences, Inc. and Dillon Hill Investment Company LLC (Filed With SEC on October 14, 2020)

Letter Agreement, dated October 9, 2020, by and among Applied DNA Sciences, Inc., Dillon Hill Capital, LLC, and Delaware Trust Company, as Collateral Agent (Filed With SEC on October 14, 2020)

Consent, dated October 9, 2020, from Dillon Hill Capital, LLC to Applied DNA Sciences, Inc (Filed With SEC on October 14, 2020)

Consulting Agreement, dated as of December 12, 2019, by and between Applied DNA Sciences, Inc. and Meadow Hill Place, LLC (Filed With SEC on August 6, 2020)

Agreement of Lease, dated November 1, 2015, by and between Applied DNA Sciences, Inc. and Long Island High Technology Incubator, Inc (Filed With SEC on August 6, 2020)

Temporary Lease Extension Agreement, dated August 9, 2019, by and between Applied DNA Sciences, Inc. and Long Island High Technology Incubator, Inc (Filed With SEC on August 6, 2020)

Amendment to Leases, dated November 4, 2019, by and between Long Island High Technology Incubator, Inc. and Applied DNA Sciences, Inc (Filed With SEC on August 6, 2020)

Amendment to Leases, dated January 17, 2020, by and between Long Island High Technology Incubator, Inc. and Applied DNA Sciences, Inc (Filed With SEC on August 6, 2020)

Description of Securities (Filed With SEC on May 14, 2020)

Warrant Agreement, dated November 15, 2019, between Applied DNA Sciences, Inc. and American Stock Transfer & Trust Company, LLC (Filed With SEC on November 18, 2019)

Underwriting Agreement entered into by and between Applied DNA Sciences, Inc. and Maxim Group LLC, as Representative of the Underwriters listed in Schedule I hereto, dated... (Filed With SEC on November 14, 2019)

Form of warrant agreement between Applied DNA Sciences, Inc. and American Stock Transfer & Trust Company, LLC (Filed With SEC on November 14, 2019)

Form of pre-funded warrant (Filed With SEC on November 14, 2019)

Form of Underwriting Agreement (Filed With SEC on November 8, 2019)

Form of Underwriting Agreement (Filed With SEC on November 1, 2019)

Form of Underwriting Agreement (Filed With SEC on October 25, 2019)

Form of warrant agreement between Applied DNA Sciences, Inc. and American Stock Transfer & Trust Company, LLC (Filed With SEC on October 25, 2019)

Form of pre-funded warrant (Filed With SEC on October 25, 2019)

Form of Subscription Agreement between investors and Applied DNA Sciences, Inc., dated August 22, 2019 (Filed With SEC on August 26, 2019)

Second Omnibus Amendment Agreement, dated July 19, 2019 by and among the Company, APDN (B.V.I.) Inc., and Delaware Trust Company, as collateral agent for the benefit of the buyers... (Filed With SEC on August 13, 2019)

Second Amendment to Intellectual Property Security Agreement, dated July 19, 2019 by the Company in favor of Delaware Trust Company as collateral agent for the secured parties... (Filed With SEC on August 13, 2019)

Second Amendment to Intellectual Property Security Agreement, dated July 19, 2019 by APDN (B.V.I.) Inc. in favor of Delaware Trust Company as collateral agent for the secured... (Filed With SEC on August 13, 2019)

Asset Purchase Agreement, dated July 29, 2019 by and between LineaRX, Inc. and Vitatex Inc (Filed With SEC on August 12, 2019)

Form of Secured Convertible Note (Filed With SEC on July 17, 2019)

Registration Rights Agreement, dated July 16, 2019 by and among Applied DNA Sciences, Inc. and the investor named on the signature page thereof (Filed With SEC on July 17, 2019)

Securities Purchase Agreement, dated July 16, 2019 by and among Applied DNA Sciences, Inc. and the investor named on the signature page thereof (Filed With SEC on July 17, 2019)

Amendment to Secured Convertible Notes, dated July 16, 2019 by and among Applied DNA Sciences, Inc. and the investors named on the signature page thereof (Filed With SEC on July 17, 2019)

Omnibus Amendment Agreement, dated July 16, 2019 by and among Applied DNA Sciences, Inc. and the parties named on the signature page thereof (Filed With SEC on July 17, 2019)

Omnibus Amendment Agreement, dated February 26, 2019, among the Company, APDN (B.V.I.), Inc., and Delaware Trust Company as collateral agent for the benefit of the buyers listed... (Filed With SEC on May 9, 2019)

First Amendment to Intellectual Property Security Agreement, dated February 26, 2019, between the Company and Delaware Trust Company as collateral agent for the benefit of the... (Filed With SEC on May 9, 2019)

First Amendment to Intellectual Property Security Agreement, dated February 26, 2019, between APDN (B.V.I.) Inc. and Delaware Trust Company as collateral agent for the benefit of... (Filed With SEC on May 9, 2019)

Patent and Know-How License and Cooperation Agreement, dated March 28, 2019, between the Company, APDN (B.V.I.), Inc., and ETCH BioTrace S.A (Filed With SEC on May 9, 2019)

Underwriting Agreement entered into by and between Applied DNA Sciences, Inc. and Maxim Group LLC, as sole underwriter, dated December 21, 2018 (Filed With SEC on December 21, 2018)

Form of Warrant (Filed With SEC on December 21, 2018)

Collateral Agency Agreement dated October 19, 2018 (Filed With SEC on December 18, 2018)

Security Agreement dated October 19, 2018 (Filed With SEC on December 18, 2018)

First Amendment to Security Agreement dated November 26, 2018 (Filed With SEC on December 18, 2018)

Guaranty and Security Agreement dated October 19, 2018 (Filed With SEC on December 18, 2018)

Intellectual Property Security Agreement dated October 19, 2018 (Filed With SEC on December 18, 2018)

Securities Purchase Agreement, dated August 31, 2018 (Filed With SEC on December 18, 2018)

Form of Note (Filed With SEC on December 10, 2018)

Registration Rights Agreement, dated August 31, 2018, by and among Applied DNA Sciences, Inc. and the investors named on the signature page there (Filed With SEC on December 10, 2018)

Securities Purchase Agreement, dated August 31, 2018, by and among Applied DNA Sciences, Inc. and the investors named on the signature page there (Filed With SEC on December 10, 2018)

Form of Convertible Note (Filed With SEC on December 6, 2018)

Registration Rights Agreement, dated November 29, 2018 by and among Applied DNA Sciences, Inc. and the investors named on the signature page there (Filed With SEC on December 6, 2018)

Securities Purchase agreement dated November 29, 2018 by and among Applied DNA Sciences, Inc. and the investors named on the signature page there (Filed With SEC on December 6, 2018)

Form of Purchase Warrant (Filed With SEC on December 20, 2017)

Placement Agency Agreement by and between Applied DNA Sciences, Inc. and Maxim Group LLC, dated December 20, 2017 (Filed With SEC on December 20, 2017)

Securities Purchase Agreement (Filed With SEC on December 20, 2017)

Confidentialmaterials omitted and filed separately with the Securities and Exchange Commission. Asterisks (***) denote omissions. LICENSE AGREEMENT (Filed With SEC on August 10, 2017)

SUBSCRIPTIONAGREEMENT (Filed With SEC on June 28, 2017)

APPLIED DNA SCIENCES, INC. COMMON STOCK PURCHASE WARRANT (Filed With SEC on November 3, 2016)

PLACEMENT AGENCYAGREEMENT (Filed With SEC on November 3, 2016)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on November 3, 2016)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 3, 2016)

SECOND AMENDMENT TO WARRANT AGREEMENT (Filed With SEC on November 3, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on August 2, 2016)

50Health Sciences Drive —Stony Brook, NY 11790 —tel ###-###-#### —fax ###-###-#### (Filed With SEC on May 12, 2016)

50 Health Sciences Drive • Stony Brook,NY 11790 • tel ###-###-#### • fax ###-###-#### (Filed With SEC on May 12, 2016)

APPLIED DNA SCIENCES, INC. 2005 INCENTIVE STOCK PLAN (Amended and Restated as of January 21, 2015) (Filed With SEC on December 14, 2015)

50Health Sciences Drive • Stony Brook, NY 11790 • tel ###-###-#### • fax ###-###-#### (Filed With SEC on December 14, 2015)

PLACEMENT AGENCYAGREEMENT (Filed With SEC on November 23, 2015)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 23, 2015)

Applied DNA Sciences, Inc. Warrant To Purchase Common Stock (Filed With SEC on November 23, 2015)

APPLIED DNA SCIENCES, INC. COMMON STOCK PURCHASE WARRANT (Filed With SEC on November 23, 2015)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 23, 2015)

ASSET PURCHASE AGREEMENT DATED SEPTEMBER 11, 2015 BY AND AMONG APPLIED DNA SCIENCES, INC., VANDALIA RESEARCH, INC. AND DEREK A. GREGG (Filed With SEC on September 17, 2015)

Confidential materials omitted and filedseparately with the Securities and Exchange Commission. Asterisks (***) denote omissions. MUTUAL LICENSE AGREEMENT (Filed With SEC on May 11, 2015)

FIRST AMENDMENT TO WARRANT AGREEMENT (Filed With SEC on April 1, 2015)

3,820,000 Shares of Common Stock and 1,528,000 Warrants to Purchase Shares of Common Stock APPLIED DNA SCIENCES, INC. UNDERWRITING AGREEMENT (Filed With SEC on March 27, 2015)

APPLIED DNA SCIENCES, INC. COMMON STOCK PURCHASE WARRANT (Filed With SEC on March 27, 2015)

2,800,000 Shares of Common Stock and 2,800,000 Warrants to Purchase Shares of Common Stock APPLIED DNA SCIENCES, INC. UNDERWRITING AGREEMENT (Filed With SEC on December 15, 2014)

WARRANT AGREEMENT Applied DNA Sciences, Inc. and American Stock Transfer & Trust Company,LLC, as Warrant Agent WARRANT AGREEMENT (Filed With SEC on November 20, 2014)

______ Shares of Common Stock and ______ Warrants to Purchase Sharesof Common Stock APPLIED DNA SCIENCES, INC. UNDERWRITING AGREEMENT (Filed With SEC on November 12, 2014)

WARRANT AGREEMENT Applied DNA Sciences, Inc. and American Stock Transfer & Trust Company,LLC, as Warrant Agent WARRANT AGREEMENT (Filed With SEC on November 12, 2014)

Applied DNA Sciences, Inc. (Filed With SEC on November 12, 2014)

______ Shares of Common Stock and ______ Warrants to Purchase Shares of CommonStock APPLIED DNA SCIENCES, INC. UNDERWRITING AGREEMENT (Filed With SEC on October 30, 2014)

WARRANTAGREEMENT APPLIEDDNA SCIENCES, INC. and AMERICANSTOCK TRANSFER & TRUST COMPANY WARRANTAGREEMENT Datedas of November ___, 2014 (Filed With SEC on October 30, 2014)

APPLIED DNA SCIENCES, INC. COMMON STOCK PURCHASE WARRANT (Filed With SEC on October 30, 2014)

WARRANT REPURCHASEOPTION AGREEMENT (Filed With SEC on October 30, 2014)

APPLIED DNA SCIENCES, INC. September 11, 2014$________ 12.5% PROMISSORY NOTE (Filed With SEC on September 17, 2014)

Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks (********) denote omissions. TERM SHEET FOR MUTUAL COOPERATION APPLIED... (Filed With SEC on July 22, 2014)

SUBSCRIPTION AGREEMENT (Filed With SEC on June 6, 2014)

WARRANT APPLIED DNA SCIENCES, INC. Warrant No.:__Issue Date: June 3, 2014 (Filed With SEC on June 6, 2014)

TERM SHEET FOR MUTUAL COOPERATION APPLIEDDNA SCIENCES, INC. / ******** (Filed With SEC on May 8, 2014)

50 Health Sciences Drive • Stony Brook,NY 11790 • tel ###-###-#### • fax ###-###-#### (Filed With SEC on December 20, 2013)

Execution Version ASSET PURCHASE AGREEMENT between REDWEB TECHNOLOGIES LIMITED and APPLIED DNA SCIENCES, INC. dated as of May10, 2013 (Filed With SEC on August 13, 2013)

AGREEMENT OF LEASE BETWEEN LONG ISLAND HIGH TECHNOLOGY INCUBATOR, INC., (Filed With SEC on August 13, 2013)

SERIES A WARRANT (Filed With SEC on July 22, 2013)

SERIES B WARRANT (Filed With SEC on July 22, 2013)

SERIES C WARRANT (Filed With SEC on July 22, 2013)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on July 22, 2013)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 22, 2013)

SUBSCRIPTION AGREEMENT (Filed With SEC on December 20, 2012)

FORM OF SERIES A WARRANT (Filed With SEC on November 29, 2012)

FORM OF SERIES B WARRANT (Filed With SEC on November 29, 2012)

FORM OF SERIES C WARRANT (Filed With SEC on November 29, 2012)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 29, 2012)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 29, 2012)

INDEMNIFICATION AGREEMENT (Filed With SEC on September 13, 2012)

APPLIED DNA SCIENCES, INC. 2005 INCENTIVE STOCK PLAN (Amended and Restated as of January 27, 2012) (Filed With SEC on May 15, 2012)

SOFTWARE DISTRIBUTION AGREEMENT (Filed With SEC on May 15, 2012)

Exclusive Sales Agreement (Agreement) (Filed With SEC on February 14, 2012)

SUBSCRIPTION AGREEMENT (Filed With SEC on December 9, 2011)

APPLIED DNA SCIENCES, INC. PURCHASE WARRANT (Filed With SEC on December 9, 2011)

JOINT DEVELOPMENT AGREEMENT (Filed With SEC on December 9, 2011)

AGREEMENT (Filed With SEC on December 9, 2011)

EMPLOYMENT AGREEMENT (Filed With SEC on December 9, 2011)

THE SCHEDULE (Filed With SEC on August 10, 2011)

SUBSCRIPTION AGREEMENT (Filed With SEC on November 26, 2010)

[FORM OF SENIOR SECURED CONVERTIBLE NOTE] (Filed With SEC on November 26, 2010)

JOINDER TO REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 26, 2010)

JOINDER TO SECURITY AGREEMENT (Filed With SEC on November 26, 2010)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on July 16, 2010)

[FORMOF SENIOR SECURED CONVERTIBLE NOTE] (Filed With SEC on July 16, 2010)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on July 16, 2010)

SECURITYAGREEMENT (Filed With SEC on July 16, 2010)

SECURITY AGREEMENT (Filed With SEC on July 16, 2010)

TRADEMARK SECURITY AGREEMENT (Filed With SEC on July 16, 2010)

PATENT SECURITY AGREEMENT (Filed With SEC on July 16, 2010)

SECURITY AGREEMENT (Filed With SEC on July 16, 2010)

[FORMOF PURCHASE WARRANT] (Filed With SEC on July 16, 2010)

APPLIED DNA SCIENCES, INC. July 15, 2010$225,000 10% SECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on July 16, 2010)

NISSHA AUTHENTICATION MARK Agreement (Filed With SEC on February 11, 2010)

*** AUTHENTICATION MARK Agreement DRAFT (Filed With SEC on February 11, 2010)

SUPPLYAND DISTRIBUTION AGREEMENT (Filed With SEC on December 23, 2009)

SUBSCRIPTIONAGREEMENT (Filed With SEC on April 20, 2009)

APPLIEDDNA SCIENCES, INC. (Filed With SEC on April 20, 2009)

SUBSCRIPTION AGREEMENT (Filed With SEC on October 11, 2007)

APPLIED DNA SCIENCES, INC. September ___, 2007 $________________ 10% SECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on October 11, 2007)

APPLIED DNA SCIENCES, INC. (Filed With SEC on October 11, 2007)

APPLIED DNA SCIENCES, INC. (Filed With SEC on August 13, 2007)

APPLIED DNA SCIENCES, INC. August ___, 2007 $________________ 10% SECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on August 13, 2007)

APPLIED DNA SCIENCES, INC. (Filed With SEC on August 3, 2007)

APPLIED DNA SCIENCES, INC. (Filed With SEC on July 10, 2007)

APPLIED DNA SCIENCES, INC. June ___, 2007 $________________ 10% SECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on July 10, 2007)

SUBSCRIPTION AGREEMENT (Filed With SEC on July 3, 2007)

APPLIED DNA SCIENCES, INC. (Filed With SEC on July 3, 2007)

Feasibility Study Agreement (Filed With SEC on July 3, 2007)

TECHNOLOGY RESELLER AGREEMENT (Filed With SEC on June 4, 2007)

PRODUCT DEVELOPMENT, MARKETING AND DISTRIBUTION AGREEMENT (Filed With SEC on May 11, 2007)

SETTLEMENT AGREEMENT AND GENERAL RELEASE OF ALL CLAIMS (Filed With SEC on May 4, 2007)

JOINT DEVELOPMENT AND MARKERTING AGREEMENT (Filed With SEC on April 24, 2007)

APPLIED DNA SCIENCES, INC. (Filed With SEC on April 24, 2007)